Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Prepaid Assets: 2009-2025

Historic Prepaid Assets for Gyre Therapeutics (GYRE) over the last 17 years, with Sep 2025 value amounting to $2.9 million.

  • Gyre Therapeutics' Prepaid Assets rose 89.89% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 89.89%. This contributed to the annual value of $2.6 million for FY2024, which is 69.68% up from last year.
  • According to the latest figures from Q3 2025, Gyre Therapeutics' Prepaid Assets is $2.9 million, which was up 6.37% from $2.7 million recorded in Q2 2025.
  • Gyre Therapeutics' 5-year Prepaid Assets high stood at $8.5 million for Q1 2021, and its period low was $697,000 during Q2 2023.
  • Over the past 3 years, Gyre Therapeutics' median Prepaid Assets value was $1.7 million (recorded in 2024), while the average stood at $2.3 million.
  • As far as peak fluctuations go, Gyre Therapeutics' Prepaid Assets crashed by 89.03% in 2022, and later spiked by 330.21% in 2025.
  • Quarterly analysis of 5 years shows Gyre Therapeutics' Prepaid Assets stood at $2.8 million in 2021, then plummeted by 69.97% to $843,000 in 2022, then spiked by 83.51% to $1.5 million in 2023, then spiked by 69.68% to $2.6 million in 2024, then soared by 89.89% to $2.9 million in 2025.
  • Its last three reported values are $2.9 million in Q3 2025, $2.7 million for Q2 2025, and $8.2 million during Q1 2025.